Match!
B. Vergès
French Institute of Health and Medical Research
447Publications
38H-index
5,065Citations
Publications 447
Newest
Abstract Background In patients with type 2 diabetes (T2D), glycaemic variability (GV), another component of glycaemic abnormalities, is a novel potentially aggravating factor for coronary artery disease (CAD). Objectives: The aim of our study was to identify interactions between GV and severity of CAD in diabetes patients admitted for acute myocardial infarction (AMI). Methods All patients with T2D admitted to our university hospital for AMI from March 2015 to February 2017 who received intrave...
#1Katharina FritzenH-Index: 1
#2Kornelia Basinska (University of Basel)
Last.Oliver SchnellH-Index: 33
view all 0 authors...
Background and Aim:Costs for the treatment of diabetes and its comorbidities are a major international issue. A recent randomized clinical trial showed that the introduction of color range indicato...
#1B. Bouillet (University of Burgundy)H-Index: 11
#2A. Rouland (University of Burgundy)H-Index: 2
Last.B. Vergès (University of Burgundy)H-Index: 38
view all 4 authors...
#1Marie-Claude Brindisi (CNRS: Centre national de la recherche scientifique)
#2Laurent Brondel (CNRS: Centre national de la recherche scientifique)H-Index: 13
Last.Thomas Mouillot (CNRS: Centre national de la recherche scientifique)H-Index: 2
view all 14 authors...
Abstract Aims GLP-1 analogues decrease food intake and have great promise for the fight against obesity. Little is known about their effects on food hedonic sensations and taste perception in poor controlled patients with type 2 diabetes (T2D). Materials and methods Eighteen T2D patients with BMI ≥25 kg/m 2 and poor controlled glycemia were studied before and after 3 months of treatment with Liraglutide. Detection thresholds for salty, sweet and bitter tastes, optimal preferences, olfactory liki...
#1B. BouilletH-Index: 11
#2Thomas Gautier (University of Burgundy)H-Index: 21
Last.Jean-Michel PetitH-Index: 21
view all 6 authors...
Aim The impact of cholesteryl ester transfer protein (CETP) on atherosclerotic development in humans remains unclear. Plasma cholesteryl ester transfer was shown to be associated with carotid intima-media thickness in type 2 diabetic (T2D) patients with adequate metabolic control. Since glycation of CETP may influence cholesteryl ester transfer processes, it is important to determine if plasma cholesteryl ester transfer is still a determinant of carotid intima-media thickness (IMT) in patients w...
12345678910